ReviewFrontiers in bioengineering and biotechnology2023
Advances in drug delivery applications of modified bacterial cellulose-based materials.
Review in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bacterial Cellulose Production by a NovelFoods (Basel, Switzerland) · 2026Article
- Upcycling of tea processing waste into kombucha-derived bioactive cellulosic composite for prospective wound dressing action.3 Biotech · 2024Article
- Review
- Revolutionizing biomedicine: advancements, applications, and prospects of nanocomposite macromolecular carbohydrate-based hydrogel biomaterials: a review.RSC advances · 2023Review
- Co-production of pigment and high value-added bacterial nanocellulose fromFrontiers in bioengineering and biotechnology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial cellulose (BC) is generated by certain species of bacteria and comprises polysaccharides with unique physical, chemical, and mechanical characteristics. Due to its outstanding biocompatibility, high purity, excellent mechanical strength, high water absorption, and highly porous structure, bacterial cellulose has been recently investigated for biomedical application. However, the pure form of bacterial cellulose is hardly used as a biomedical material due to some of its inherent shortcomings. To extend its applications in drug delivery, modifications of native bacterial cellulose are widely used to improve its properties. Usually, bacterial cellulose modifications can be carried out by physical, chemical, and biological methods. In this review, a brief introduction to bacterial cellulose and its production and fabrication is first given, followed by up-to-date and in-depth discussions of modification. Finally, we focus on the potential applications of bacterial cellulose as a drug delivery system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.